期刊文献+

精神分裂症患者应用利培酮导致的不良反应分析 被引量:2

Analysis of Adverse Reactions Induced by Risperidone in Schizophrenic Patients
下载PDF
导出
摘要 目的分析精神分裂症患者应用利培酮后的不良反应发生情况,为精神科安全用药提供参考。方法随机抽取我院2016年1月至2016年12月收治的服用利培酮的精神分裂症患者100例进行回顾性分析。结果利培酮不良反应发生率为78%,主要为锥体外系反应、心血管系统反应、失眠、焦虑、体重增加、血清催乳素升高等。结论利培酮作为新型非典型抗精神病药物,目前在临床广泛应用,但是它的不良反应发生率仍然较高,涉及多个系统、器官,应引起医务人员的高度重视,做到早期预防、密切观察、准确判断、及时干预。 OBJECTIVE To analyze the incidence of adverse reactions of risperidone in patients with schiz- ophrenia, and to provide reference for safe drug use in psychiatric department. METHODS 100 schizophren- ic patients taking risperidone in our hospital from Janu- ary 2016 to December 2016 were randomly selected for retrospective analysis. RESULTS The incidence of risperidone adverse reaction was 78%, mainly being of extrapyramidal reaction, cardiovascular system response, insomnia, anxiety, weight gain, high serum prolactin lev- el etc. CONCLUSION As a new atypical antipsychot- ic drug, risperidone was widely used in clinical practice, but the incidence of adverse reactions was still high,in- volving multiple systems and organs, which should cause medical staff to pay high attention to early prevention, close observation, accurate judgement and timely inter- vention.
机构地区 徐州精神病院
出处 《海峡药学》 2017年第12期267-268,共2页 Strait Pharmaceutical Journal
关键词 利培酮 不良反应 分析 risperidone adverse reaction analysis
  • 相关文献

参考文献5

二级参考文献37

  • 1丁杰锋.高催乳素血症诊断研究进展[J].医学研究杂志,2007,36(7):106-108. 被引量:13
  • 2Kern RS, Green MF, Comblatt BA, et al. The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine [ J ]. Psycopharmacology,2006,187 : 312-320.
  • 3Kasper S, Lerman MN, Mcquade RD, et al. Efficacy and safety of aripiprazole vs haloperidol for long-erm maintenance treatment following acute relapse of schizophrenia [ J ]. Int J Neuropsychopharmacol,2003,6 : 325-337.
  • 4Hanssens L, LItalien G, Loze JY, et al. The effect of antipsychotic medication on sexual function andserum prolactin levels in community - treated schizophrenic patients : results from the Schizophrenia Trial of Aripiprazole (STAR) study ( NCT00237913 ) [ J]. Bmc Psychiatry ,2005,8 : 95.
  • 5Aihara K, Shimada J, Miwa T, et al. The novel antipsychotic aripiprazole is a partial of adenyl cyclase activity and prolactin release [ J ]. Brain Research ,2004,1003 : 9-17.
  • 6De Herr M, Hanssens L, van Winkel R, et al. A case series:evaluation of the metabolic safety of aripiprazole [ J ]. Schizophr Bull. 2007,33 : 823-830.
  • 7沈渔邨.精神病学[M].第5版.北京:人民卫生出版社,2009:215.
  • 8Luciano AA. Clinical presentation of hyperprolactinemia. J Reprod Med ,1999 ,44 (12 Suppl) :1085.
  • 9Smith CR, Norman MR. Prolactin and growth hormone: molecular heterogeneity and measurement in serum. Ann Clin Biochem, 1990, 27(4) :542 -550.
  • 10Pinilla I,, Tene - Sempere M, Aguilar R, et al . Effect of N - methyl D- aspartic acid and kainic acid on prolactin secretion in hyper and hypoprolactinaemic conditions . Eur J Endocrinol, 1998,138 ( 4 ) 460 - 466.

共引文献58

同被引文献19

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部